Medicines, Medical Devices, Cosmetics, Food Supplements
Your one-stop-shop solution in pharma & healthcare
Everything in One Place
Your Personalized Pharmacy
What are you looking for?
Are you into…
WHAT ARE OUR areas of expertise?
We are into …
Our DNA
We are NOT just another consultant
Who We Are
We are … in2pharma !
Regulatory Intelligence
and … we are into sharing !
Update Adverse drug reaction reporting details
Luxembourg On January 17th, EMA published the newest version (v28) of QRD Appendix V. In this version, the contact details for reporting adverse drug reactions in Luxemburg has been changed, to include the German version of the address. Luxembourg/Luxemburg [French]...
Planning tool for requesting timeslots expanded to more procedures
The Netherlands Via the MEB website, a planning tool is already available to reserve a timeslot for requesting assessment procedures for decentralized procedures. The planning tool helps the MEB to properly plan the required capacity. This tool has now been expanded...
Publication Royal Decree on Nutrivigilance
Belgium Since 03 December 2023, a new royal decree has been published regarding the reporting of adverse reactions related to the use of food supplements. This Royal Decree defines the legal framework for Nutrivigilance, but not its mode of operation in...
Phone
+32 16 891 600
Location
Hof Ter Loonst
Terloonststraat 22
1910 Kampenhout
Belgium
info@in2pharma.com